We are live on ! Find out more
PAI

ProQuest Associates IV Portfolio holdings

AUM $53M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
+76.09%
1 Year Est. Return
+3.35%
3 Year Est. Return
+113.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$487M
AUM Growth
+$180M
Cap. Flow
-$10.2M
Cap. Flow %
-2.09%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
IMDZ
Immune Design Corp.
IMDZ
+$10.2M

Sector Composition

1 Healthcare 83.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$387M 79.39%
4,780,188
– –
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
$41M 8.41%
1,983,858
-430,182
-18% -$10.2M
AGRX
3
DELISTED
Agile Therapeutics
AGRX
$40.1M 8.24%
2,334
– –
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$16.4M 3.36%
237,500
– –
ZSAN
5
DELISTED
Zosano Pharma Corporation
ZSAN
$1.67M 0.34%
328
– –
SVRA icon
6
Savara
SVRA
$1.17B
$1.25M 0.26%
36,455
– –

Similar funds

CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
HC
Hampstead Capital London, United Kingdom $55.8M AUM 2.76% 1-Year Est. Return
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
SCM
Sorin Capital Management Stamford, Connecticut $56.7M AUM 2.84% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return